Outcomes Associated With Standardized Ideal Body Weight Dosing of Intravenous Immune Globulin in Hospitalized Patients: A Multicenter Study.

There are limited outcomes data for ideal body weight (IBW)-based dosing of intravenous immune globulin (human, IVIG) in hospitalized patients. To investigate clinical outcomes associated with a standardized change from total body weight to IBW-based dosing of IVIG. This was a retrospective, multicenter, pre-post sequential period analysis.